O

Onesource Specialty Pharma Ltd
NSE:ONESOURCE

Watchlist Manager
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
Watchlist
Price: 1 618 INR 1.56% Market Closed
Market Cap: 185.3B INR

Operating Margin
Onesource Specialty Pharma Ltd

15.6%
Current
14%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.6%
=
Operating Profit
1.9B
/
Revenue
12.1B

Operating Margin Across Competitors

No Stocks Found

Onesource Specialty Pharma Ltd
Glance View

Onesource Specialty Pharma Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Bangalore, Karnataka and currently employs 525 full-time employees. The company went IPO on 2025-01-24. OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. The company operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The firm specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. The company supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The firm caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.

ONESOURCE Intrinsic Value
2 276.94 INR
Undervaluation 29%
Intrinsic Value
Price
O
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
15.6%
=
Operating Profit
1.9B
/
Revenue
12.1B
What is the Operating Margin of Onesource Specialty Pharma Ltd?

Based on Onesource Specialty Pharma Ltd's most recent financial statements, the company has Operating Margin of 15.6%.

Back to Top